Buprenorphine Transdermal Patches Market Is Likely to Experience a Tremendous Growth by 2028
The global buprenorphine transdermal patches market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Buprenorphine patches are used as a pain reliever and belongs to a class of medications called opiate (narcotic) analgesics. They support to relieve severe pain in people who need pain medication around the clock for a long time and that cannot be treated with other medications. The major factor driving the demand for the global buprenorphine transdermal patches market is the increasing demand and application as a pain reliever across the globe.
Moreover, these patches are
marketed as a Schedule III medicine. It is used for the management of pain
severe enough to require daily, around-the-clock and for long-term opioid
treatment. Additionally, the market is also growing owing to the improvement in
inpatient drug delivery during the forecast period. However, the growth of the
market is hampered due to several side effects related to these patches.
To Request a Sample of our Report on Buprenorphine
Transdermal Patches Market: https://www.omrglobal.com/request-sample/buprenorphine-transdermal-patches-market
Some major players in the
market include Grunenthal, PurduePharma, Luye Pharma, among others. The market
players are contributing significantly to the growth of the market by the
adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in April 2020,
Amneal Pharmaceuticals announced the approval of Abbreviated New Drug
Application (ANDA) for a generic version of Butrans (buprenorphine) Transdermal
System from the US Food and Drug Administration (FDA). The company received the
approval for Butrans in 5 mcg/hr, 7.5 mcg/hr, 10 mcg/hr, 15 mcg/hr and 20
mcg/hr. Additionally, the company was also granted the Competitive Generic
Therapy (CGT) designation and 180 days of exclusivity for the 7.5 mcg/hr dose.
Market Coverage
• The
market number available for – 2022-2028
• Base
year- 2021
• Forecast
period- 2022-2028
Segment Covered-
•
By Type
•
By Application
Regions Covered-
•
North America
•
Europe
•
Asia-Pacific
•
Rest of the World
Competitive Landscape- Grunenthal, Luye Pharma, and
Amneal Pharmaceuticals, among others.
A
full Report of Buprenorphine Transdermal Patches Market is Available @ https://www.omrglobal.com/industry-reports/buprenorphine-transdermal-patches-market
Global Buprenorphine Transdermal Patches Market Report by
Segment
By Type
•
5mcg/h
•
7.5mcg/h
•
10mcg/h
•
15 mcg/h
•
20 mcg/h
By Application
•
Cancer Pain
•
Others
Global Buprenorphine Transdermal Patches Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment